Press release summary
Thermo Fisher Scientific has introduced Gibco VaxEvo CD 293 Medium, a chemically defined, animal-origin-free cell-culture medium for suspension HEK293 workflows used to produce adenovirus and adenoviral vectors.
The company said the medium will be offered in liquid form and in multiple Advanced Granulation Technology package sizes, allowing process-development teams to use the same formulation as work moves toward scale-up and manufacturing. Thermo Fisher positions the product for human and animal vaccine developers as well as other adenovirus-based applications.
In company benchmarking studies, VaxEvo CD 293 produced average adenovirus type 5 titers comparable to selected competing media. Thermo Fisher reported titers as much as 5.7 times higher in some comparisons, including against media used with their recommended feeds. Those results are supplier-reported and have not been independently verified in the announcement.
Why it matters to laboratory readers
Upstream media selection can affect cell growth, viral yield, raw-material consistency and the difficulty of transferring a process from development to manufacturing. A feed-free, animal-origin-free option could simplify suspension HEK293 workflows and reduce variability, but laboratories will still need application-specific comparability, scale-down and process-characterization studies before changing established methods.
Original source: Thermo Fisher Scientific, Nov. 18, 2026.







Leave a Reply